Second Conjoint Meeting of RIKEN and ISM
We are pleased to announce the Second Conjoint Meeting between ISM and RIKEN, which will take place from September 24-25 at The University of Tokyo, in Tokyo, Japan.
After the success of the first RIKEN-ISM meeting in Tokyo, which gathered participants from many countries and scientific fields, the International Society of Microbiota and RIKEN welcome the global microbiome community for a new edition of this interdisciplinary scientific meeting. Read More
Key Dates & Agenda
RIKEN-ISM Tokyo Meeting 2026 Speakers
Call for Innovation
RIKEN-ISM Tokyo Meeting 2026 Confirmed Speakers
Can IgA Reprogram the Human Gut Microbiota in Inflammatory Bowel Disease?
Reiko Shinkura, The University of Tokyo, Japan
Oral-to-Gut Bacterial Translocation in Cardiovascular Diseases
Yoshikazu Nakaoka, National Cerebral and Cardiovascular Center Research Institute, Japan
When Synapses Shape the Microbiome: Decoding the Gut–Brain Axis in Autism
Elisa Hill-Yardin, RMIT University, Australia
From Quorum-Sensing-Driven Pathogenesis to Microbiome: Targeted Therapies in Atopic Dermatitis
Yumi Matsuoka, The University of Osaka, Japan
Microbial Metabolites as Drivers of Gastric Mucosal Defense
Naoko Satoh-Takayama, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Microbiota-Metabolite Control of Cardiac Injury and Repair
Patrick C.H. Hsieh, Institute of Biomedical Sciences, Academia Sinica, Taiwan
The Microbiota–Muscle Axis in Aging: How Trimethylamine N-Oxide (TMAO) Remodels Mitochondria and Promotes Sarcopenia
Ippei Shimizu, National Cerebral and Cardiovascular Center Research Institute, Japan
Single-Cell Visualization and Australia’s Human Microbiome Biobank: New Tools for Strain-Level Microbiome Science
Gene Tyson, Queensland University of Technology, Australia
From Strain Diversity to Mobile Element Dynamics in Human Microbiomes with Single-Cell Genomics
Masahito Hosokawa, Waseda University, Japan
Rapid, Single-Cell-Precision Profiling for Probiotic Quality and Source-Tracking
Jian Xu, Qingdao Institute of BioEnergy and Bioprocess Technology, China
Living Probiotics, Microbial Metabolites, and Mitochondrial Resilience: A Pathway to Healthy Aging
Dongryeol Ryu, Gwangju Institute of Science and Technology (GIST), Korea
Engineering Mitochondrial Stress Tolerance through Mitochondria-Targeted Nanocapsules: Perspectives on the Microbiota–Mitochondria Axis
Yuma Yamada, Hokkaido University, Japan
Carotenoid Metabolism Regulates the Microbiota–Mitochondria Axis: From Diet to Single-Cell Heterogeneity
Dingbo Lin, Oklahoma State University, USA
Strain and Function-Resolved Metagenomics to Identify Microbial Drivers of Chronic Disease
Wataru Suda, RIKEN Center for Integrative Medical Sciences (IMS), Japan
Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy
Sin-Hyeog Im, Pohang University of Science and Technology (POSTECH), Korea
Development of Smart Biodelivery Systems for Personalized Disease Treatment Based on the Gut Microbiome
GwangPyo Ko, Seoul National University, Korea
Who is Attending RIKEN-ISM Tokyo Meeting 2026
Academia Sinica, Taiwan
Gastro Solutions, Mexico
Gwangju Institute of Science and Technology (GIST), South Korea
Hospital Universitario de A Coruña, Spain
INSERM, France
Kyoto University, Japan
Mahidol University, Thailand
Medical University of Warsaw, Poland
National Cerebral and Cardiovascular Center Research Institute, Japan
National Defense Medical University, Taiwan
National Institute of Genetics, Japan
National Taiwan University, Taiwan
Oklahoma State University, United States
Pohang University of Science and Technology (POSTECH), South Korea
Qingdao Institute of BioEnergy and Bioprocess Technology, China
Queensland University of Technology (QUT), Australia
RIKEN Center for Integrative Medical Sciences (IMS), Japan
RMIT University, Australia
Samsung Medical Center, South Korea
Seoul National University, South Korea
Taizhou Changxin Biotechnology Co., Ltd., China
The University of Osaka, Japan
The University of Tokyo, Japan
Universidad de Magallanes, Chile
University of the Ryukyus, Japan
Virginia Commonwealth University, United States
Waseda University, Japan
Updated till 20th July, 2026…
Advancing Microbiota Research into Medicine
Japan’s Contributions to Mechanism, Translation, and Clinical Impact
Over the course of this meeting, one message has emerged with clarity: microbiota research in Japan has reached a level of scientific maturity characterized by mechanistic depth and growing clinical relevance. The work presented here reflects not only technical excellence, but also a sustained effort to connect fundamental microbiology with medical application.
Tokyo Microbiota 2025 Recognizes Excellence in Science, Health Impact, and Innovation
Tokyo Microbiota 2025 celebrated outstanding contributions to microbiota research through its Scientific Awards, Healthy Impact Awards, and Innovation Awards, highlighting progress from fundamental science to clinical and industrial innovation.
Abstracts Book 2025 and VOD
The abstracts book and VOD bring together all scientific contributions presented at the meeting, from oral communications and poster sessions to innovation-focused presentations. It reflects the diversity of topics discussed and provides a complete overview of the research shared during the conference.
